SCHEMBL25600548

SCHEMBL25600548

CCC1(CC)c2cc(-c3ccccc3)ccc2-c2c1c1c(c3cc(OC)ccc23)OC(c2ccc(-c3ccccc3)cc2)(c2ccc(N3CCOCC3)cc2)C=C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
TSHR P16473 3/20 0.34
KDM4E B2RXH2 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
HSD17B10 Q99714 2/20 0.34
TP53 P04637 1/20 0.34
PRKDC P78527 1/20 0.34
AKT1 P31749 1/20 0.33
MAPK1 P28482 3/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
ADAM17 P78536 1/20 0.33
PTPN1 P18031 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25600545 0.99 PRKDC (0.35) ALDH1A1TSHRKDM4ETDP1HSD17B10
SCHEMBL25600428 0.97 PRKDC (0.35) ALDH1A1TSHRKDM4ETDP1HSD17B10
SCHEMBL25607263 0.96 AKT1 (0.35) ALDH1A1TSHRKDM4ETDP1HSD17B10
SCHEMBL25600769 0.96 PRKDC (0.38) ALDH1A1KDM4ETDP1PRKDCAKT1
SCHEMBL25600547 0.94 PRKDC (0.32) ALDH1A1TSHRKDM4ETDP1HSD17B10
SCHEMBL25600429 0.93 KDM4E (0.35) ALDH1A1KDM4ETDP1PRKDCMAPK1
SCHEMBL26627754 0.93 NTSR1 (0.35) ALDH1A1KDM4EPRKDCAKT1KMT2A
SCHEMBL25600543 0.93 PRKDC (0.33) ALDH1A1TSHRKDM4ETDP1HSD17B10
SCHEMBL25600425 0.93 ADAM17 (0.36) ALDH1A1TSHRKDM4EHSD17B10PRKDC
SCHEMBL25600424 0.92 RAB9A (0.36) ALDH1A1TSHRKDM4EHSD17B10PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
EP-4198102-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 ALDH1A1 1091/4885TSHR 1015/4885KDM4E 3270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.